Flawed studies linking hormone therapy to breast cancer made doctors reluctant to prescribe it for menopause relief - especially for breast cancer survivors
Recent medical re-evaluations suggest that previous studies linking hormone therapy to breast cancer were flawed, leading to a shift in clinical perspectives. The FDA has begun removing warning labels, potentially improving access to menopause relief for women.
Women under 50 may experience early-onset menopause as a result of cancer treatment. Kathrin Ziegler/DigitalVision via Getty Images Flawed studies linking hormone therapy to breast cancer made doctors reluctant to prescribe it for menopause relief – especially for breast cancer survivors Published: July 30, 2026 8:07am EDT https://theconversation.com/flawed-studies-linking-hormone-therapy-to-breast-cancer-made-doctors-reluctant-to-prescribe-it-for-menopause-relief-especially-for-breast-cancer-survivors-277352 https://theconversation.com/flawed-studies-linking-hormone-therapy-to-breast-cancer-made-doctors-reluctant-to-prescribe-it-for-menopause-relief-especially-for-breast-cancer-survivors-277352 Link copied Share article Share article
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in